[Idiopathic granulomatous mastitis].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 22981187)

Published in Rev Med Interne on September 13, 2012

Authors

M Hello1, A Néel, J Graveleau, A Masseau, C Agard, J Caillon, M Hamidou

Author Affiliations

1: Service de médecine interne, CHU Hôtel-Dieu, place Alexis-Ricordeau, 44093 Nantes, France.

Articles by these authors

Pancytopenia and severe cytopenia induced by low-dose methotrexate. Eight case-reports and a review of one hundred cases from the literature (with twenty-four deaths) Rev Rhum Engl Ed (1996) 2.69

Why is antimicrobial de-escalation under-prescribed for urinary tract infections? Infection (2012) 2.04

Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney Int (1993) 1.56

Systemic lupus erythematosus associated with ANCA-associated vasculitis: an overlapping syndrome? Rheumatol Int (2011) 1.49

[Appropriate use of antibiotics in hospitals. Investigating clinical practices in management of community-acquired pneumonia]. Presse Med (2005) 1.39

[Peripheral inflammatory rheumatism during Horton's disease]. Presse Med (1990) 1.38

Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients. Ann Rheum Dis (2007) 1.35

Pulmonary fibrosis associated with ANCA-positive vasculitides. Retrospective study of 12 cases and review of the literature. Ann Rheum Dis (2008) 1.15

Unique B cell differentiation profile in tolerant kidney transplant patients. Am J Transplant (2013) 1.14

Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients. Br J Haematol (1998) 1.12

Intrauterine infection induces programmed cell death in rabbit periventricular white matter. Pediatr Res (2000) 1.12

In vivo simulation of human pharmacokinetics in the rabbit. Bull Math Biol (1998) 1.08

Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model. Antimicrob Agents Chemother (1997) 1.04

Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis. Int J Antimicrob Agents (2010) 1.04

Lung distribution and pharmacokinetics of aerosolized tobramycin. Am Rev Respir Dis (1993) 1.03

Isolation of Bacteroides strains with reduced sensitivity to 5-nitroimidazoles. Eur J Clin Microbiol (1986) 1.02

Recurrent pneumonia due to rifampicin-resistant Rhodococcus equi in a patient infected with HIV. J Infect (1992) 0.95

[Orofacial manifestations of systemic sclerosis: A study of 30 consecutive patients]. Rev Stomatol Chir Maxillofac (2010) 0.95

Influence of isostatic compression on the stability of vancomycin loaded with a calcium phosphate-implantable drug delivery device. J Biomed Mater Res (2000) 0.95

Dynamics of ceftazidime-pefloxacin interaction shown by a new killing curve-chequerboard method. J Antimicrob Chemother (1987) 0.95

Fabry disease 'The New Great Imposter': results of the French Observatoire in Internal Medicine Departments (FIMeD). Clin Genet (2011) 0.95

[Orofacial manifestations of systemic sclerosis: a study of 30 consecutive patients]. Rev Med Interne (2008) 0.94

In vivo efficacy of continuous infusion versus intermittent dosing of ceftazidime alone or in combination with amikacin relative to human kinetic profiles in a Pseudomonas aeruginosa rabbit endocarditis model. J Antimicrob Chemother (2001) 0.93

Assessment of formulas for calculating critical concentration by the agar diffusion method. Antimicrob Agents Chemother (1987) 0.93

[Lipo-atrophy of the buttocks after intramuscular injection of adrenal cortex hormones]. Rev Med Interne (1992) 0.92

Influence of pH on adaptive resistance of Pseudomonas aeruginosa to aminoglycosides and their postantibiotic effects. Antimicrob Agents Chemother (1996) 0.92

Systemic and immune manifestations in myelodysplasia: a multicenter retrospective study. Arthritis Care Res (Hoboken) (2011) 0.92

Identification of factors affecting in vivo aminoglycoside activity in an experimental model of gram-negative endocarditis. Antimicrob Agents Chemother (1992) 0.92

Cervical spine involvement in psoriatic arthritis. J Rheumatol (1989) 0.91

A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year followup study of 164 patients. J Rheumatol (2000) 0.91

Vasculitis restricted to the lower limbs: a clinical and histopathological study. Ann Rheum Dis (2006) 0.91

Churg-Strauss syndrome revealed by granulomatous acute pericarditis: two case reports and a review of the literature. Semin Arthritis Rheum (2007) 0.91

[Metachromatic leucodystrophy in a young adult; clinical, biological and ultrastructural study]. Rev Neurol (Paris) (1970) 0.91

[Hemophagocytic syndromes. A series of 23 cases]. Ann Med Interne (Paris) (1996) 0.90

Patterns of cerebral inflammatory response in a rabbit model of intrauterine infection-mediated brain lesion. Brain Res Dev Brain Res (2003) 0.90

[Probable pancreatic encephalopathy treated with antitrypsin compounds]. Presse Med (1968) 0.89

[Cardiac involvement in Wegener's granulomatosis: report of four cases and review of the literature]. Rev Med Interne (2009) 0.89

Antiendothelial cell antibodies in vasculitis and connective tissue disease. Ann Rheum Dis (2006) 0.88

Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlation. Antimicrob Agents Chemother (1991) 0.88

[Comparison of the bactericidal activity of three aminosides: gentamicin, tobramycin and amikacin]. Pathol Biol (Paris) (1987) 0.88

Schnitzler syndrome: a dramatic improvement with anakinra. J Eur Acad Dermatol Venereol (2008) 0.87

A case of biliary tract infection caused by Haemophilus parainfluenzae. Eur J Clin Microbiol Infect Dis (1992) 0.87

Resistance to methicillin and virulence of Staphylococcus aureus strains in bacteriemic cancer patients. Intensive Care Med (1993) 0.87

Actinomycosis of the gallbladder due to Actinomyces naeslundii. J Infect (1987) 0.86

Occult Hodgkin lymphoma presenting as polymyalgia rheumatica: value of [18F]-FDG positron emission tomography. Ann Hematol (2009) 0.85

[Peripheral neuropathies caused by disulfiram (antabuse)]. Rev Neurol (Paris) (1972) 0.85

A rare gynecological case of paraneoplastic cerebellar degeneration discovered by FDG-PET. Gynecol Oncol (2007) 0.85

[Non tuberculous mycobacterial infections]. Rev Med Interne (2007) 0.84

[Acquired Willebrand syndrome with lymphoproliferative disorders]. Presse Med (1997) 0.84

A delivery system of linezolid to enhance the MRSA osteomyelitis prognosis: in vivo experimental assessment. Eur J Clin Microbiol Infect Dis (2012) 0.84

Efficacy of rituximab in primary Sjogren's syndrome with peripheral nervous system involvement: results from the AIR registry. Ann Rheum Dis (2011) 0.84

[Prior use of anti-inflammatory and antibiotic drugs in patients hospitalized for peritonsillar abscess]. Med Mal Infect (2009) 0.84

Different aminoglycoside-resistant phenotypes in a rabbit Staphylococcus aureus endocarditis infection model. Antimicrob Agents Chemother (2002) 0.83

[Cyriax's slipping rib syndrome]. Presse Med (1987) 0.83

Therapeutic amoxicillin levels achieved with oral administration in term neonates. Eur J Clin Pharmacol (2007) 0.83

Almond oil implicated in a Staphylococcus capitis outbreak in a neonatal intensive care unit. J Perinatol (2007) 0.83

[Horton's disease in elderly patients aged over 75: clinical course, complications of corticotherapy. Comparative study of 164 patients. Towards a reduced initial dose]. Rev Med Interne (2001) 0.82

[Central nervous system vasculitides: an update]. Rev Med Interne (2012) 0.82

In vivo antibacterial effects of simulated human serum profiles of once-daily versus thrice-daily dosing of amikacin in a Serratia marcescens endocarditis experimental model. Antimicrob Agents Chemother (1996) 0.82

In vivo bactericidal activities of ciprofloxacin and pefloxacin in an experimental model of Serratia marcescens endocarditis. Antimicrob Agents Chemother (1994) 0.82

[Primary hypereosinophilic syndrome]. Ann Dermatol Venereol (2006) 0.82

The effect of rifampicin on adaptive resistance of Pseudomonas aeruginosa to aminoglycosides. J Antimicrob Chemother (1996) 0.81

[Aortitis in giant cell arteritis and its complications]. Rev Med Interne (2013) 0.81

Reactive haemophagocytic syndrome in AIDS. AIDS (1996) 0.81

Cefepime and amikacin synergy against a cefotaxime-susceptible strain of Enterobacter cloacae in vitro and in vivo. J Antimicrob Chemother (1997) 0.81

A 5-year prospective follow-up study in essential cryofibrinogenemia patients. Autoimmun Rev (2011) 0.81

Comparative efficacies of ciprofloxacin and pefloxacin alone or in combination with fosfomycin in experimental endocarditis induced by multidrug-susceptible and -resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother (1995) 0.81

Multidimensional analysis of clinical symptoms in patients with Fabry's disease. Int J Clin Pract (2013) 0.81

A new experimental model of acute osteomyelitis due to methicillin-resistant Staphylococcus aureus in rabbit. Lett Appl Microbiol (2011) 0.81

Escherichia coli antibiotic resistance in emergency departments. Do local resistance rates matter? Eur J Clin Microbiol Infect Dis (2014) 0.81

Outcome of essential cryofibrinogenaemia in a series of 61 patients. Rheumatology (Oxford) (2008) 0.80

[Prevalence and description of hyponatremia in internal medicine departments of the France west area. A "one day" multicentric descriptive study]. Rev Med Interne (2006) 0.80

[Bactericidal effect of piperacillin alone and combined]. Presse Med (1986) 0.80

Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center. J Thromb Haemost (2014) 0.80

Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies. Eur Respir J (2011) 0.80

Who are the carriers of MRSA in the community? A prospective study in the Pays de la Loire region of France. Clin Microbiol Infect (2009) 0.80

[Reversible cerebral vasoconstriction syndrome]. Rev Med Interne (2012) 0.79

Two cases of atypical Whipple's disease associated with cytoplasmic ANCA of undefined specificity. Scand J Rheumatol (2012) 0.79

Treatment of experimental rabbit infective endocarditis due to a multidrug-resistant Pseudomonas aeruginosa with high-dose ceftazidime alone and combined with amikacin or sulbactam or both. J Antimicrob Chemother (1995) 0.79

[Progressive multifocal leukoencephalopathy following kidney transplantation]. J Neurol Sci (1974) 0.79

Risk factors and pathogens involved in early ventilator-acquired pneumonia in patients with severe subarachnoid hemorrhage. Eur J Clin Microbiol Infect Dis (2013) 0.78

Susceptibility to the main antibiotics of Escherichia coli and Staphylococcus aureus strains identified in community acquired infections in France (MedQual, 2004-2007). Med Mal Infect (2009) 0.78

[Venous leiomyosarcoma mimicking deep venous thrombosis: contribution of positron emission tomography]. J Mal Vasc (2008) 0.78

[Sweet's syndrome as the presenting manifestation of relapsing polychondritis]. Rev Med Interne (2010) 0.78

[NK cells: new insights on physiology and clinical implication in diseases]. Rev Med Interne (2005) 0.78

An atypical case of X-linked lymphoproliferative disease revealed as a late cerebral lymphoma. J Neuroimmunol (2009) 0.78

Vasa-vasoritis of the aorta and fatal myocarditis in fulminant Churg-Strauss syndrome. Rheumatology (Oxford) (2008) 0.78

[Screening of abdominal aortic involvement using Doppler sonography in active giant cell (temporal) arteritis at the time of diagnosis. A prospective study of 30 patients]. Rev Med Interne (2007) 0.78

Large discrepancies in linezolid use between French teaching hospitals: A comment on "Antimicrobial stewardship and linezolid". Int J Clin Pharm (2015) 0.78

[Partial motor epilepsy in nonketotic hyperglycemia. 2 cases]. Presse Med (1984) 0.78

The optimal aminoglycoside and its dosage for the treatment of severe Enterococcus faecalis infection. An experimental study in the rabbit endocarditis model. Eur J Clin Microbiol Infect Dis (2012) 0.77

[Community-acquired pneumonia caused by Staphylococcus aureus in non-HIV infected adult patients]. Rev Pneumol Clin (1999) 0.77